Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer Vaccines Immunology
Scientists at University of Tubingen, Department of Internal Medicine II describe research in cancer vaccines immunology
September 23rd, 2008
Research findings, 'Generation of antigen-specific CTL responses using RGS1 mRNA transfected dendritic cells,' are discussed in a new report. "Advances in tumor immunology and Identification of tumor-associated antigens (TAAs) provide a basis for the development of novel immunotherapies to treat malignant diseases. In order to identify novel TAAs, we performed comparative microarray analysis of (heterogeneous) tissues and found regulator of G protein-signaling 1 (RGS1) extensively up-regulated in renal cell carcinoma (RCC) tissues," investigators in Tubingen, Germany report. "To examine the possible function of this molecule as a novel, broadly applicable TAA, synthetic...
Source: Cancer Weekly (2008-09-23)
|
